Cargando…
PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431638/ http://dx.doi.org/10.1097/01.HS9.0000850300.53785.f4 |
| _version_ | 1784780111468298240 |
|---|---|
| author | Jurczak, W. Dartigeas, C. Coscia, M. Ganly, P. Al-Jazayrly, G. Wang, C. Bao, K. Leow, C. C. Shahda, S. Zinzani, P. L. |
| author_facet | Jurczak, W. Dartigeas, C. Coscia, M. Ganly, P. Al-Jazayrly, G. Wang, C. Bao, K. Leow, C. C. Shahda, S. Zinzani, P. L. |
| author_sort | Jurczak, W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431638 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94316382022-08-31 PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS) Jurczak, W. Dartigeas, C. Coscia, M. Ganly, P. Al-Jazayrly, G. Wang, C. Bao, K. Leow, C. C. Shahda, S. Zinzani, P. L. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431638/ http://dx.doi.org/10.1097/01.HS9.0000850300.53785.f4 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Jurczak, W. Dartigeas, C. Coscia, M. Ganly, P. Al-Jazayrly, G. Wang, C. Bao, K. Leow, C. C. Shahda, S. Zinzani, P. L. PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS) |
| title | PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS) |
| title_full | PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS) |
| title_fullStr | PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS) |
| title_full_unstemmed | PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS) |
| title_short | PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS) |
| title_sort | pb1862: bruin cll-313: a phase 3 open-label, randomized study of pirtobrutinib vs bendamustine+rituximab in untreated patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (trial in progress) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431638/ http://dx.doi.org/10.1097/01.HS9.0000850300.53785.f4 |
| work_keys_str_mv | AT jurczakw pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT dartigeasc pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT cosciam pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT ganlyp pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT aljazayrlyg pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT wangc pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT baok pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT leowcc pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT shahdas pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress AT zinzanipl pb1862bruincll313aphase3openlabelrandomizedstudyofpirtobrutinibvsbendamustinerituximabinuntreatedpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphomatrialinprogress |